Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA4R4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,443
Award facts
- Contract value 100% obligated
- $43,443.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,443.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors. This is a non-set-aside competitive award with an ultimate completion date of February 5, 2026, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Department of Defense and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling federal pharmaceutical requirements through open competition, with its DLA contract portfolio encompassing a comprehensive range of medications across multiple therapeutic domains including specialty pharmaceuticals, vaccines, and medical devices. This delivery order for Zepbound, a weight-loss medication, reflects the company's ongoing role in supplying essential pharmaceutical products to support military medical operations and personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FA4R4?
SPE2DR26FA4R4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FA4R4 worth?
The government has obligated $43,443 on SPE2DR26FA4R4.
Is contract SPE2DR26FA4R4 an order under another contract?
Yes. SPE2DR26FA4R4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA4R4 competed?
The extent of competition for SPE2DR26FA4R4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award